The German government has committed to provide Israel with the option of procuring the Covid-19 vaccine being developed by AstraZeneca plc (LSE: AZN), if it is found to be safe and effective, the Israeli Embassy in Germany has told "Globes."
The EU has signed an agreement with UK-Swedish company AstraZeneca to reserve 400 million vaccinations, and according to the Israeli Embassy in Berlin, Germany will insist that Israel, which is an associate member of the EU, will be considered part of the EU.
The commitment was given to Israeli Foreign Minister Gabi Ashkenazi and Israeli Ambassador to Germany Jeremy Issacharoff by German Foreign Minister Heiko Maas and Health Minister Jens Spahn. However, it is unclear how quickly such large amounts of the vaccine, being developed in partnership with Oxford University, can be delivered. The Covid-19 vaccine is currently in advanced Phase III human trials.
Spokesperson for the Israeli Embassy in Germany Shir Gidon said, "Germany sees Israel as part of Europe in terms of procuring the vaccine and therefore it will be permitted to convey the vaccine for use in Israel when it is approved."
The deal is part of Germany's 'special relationship' with Israel and its commitment to Israel's safety and security.
Published by Globes, Israel business news - en.globes.co.il - on October 13, 2020
© Copyright of Globes Publisher Itonut (1983) Ltd. 2020